Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck

about

Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck

Item

http://www.wikidata.org/entity/Q36143844

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Randomized phase II trial of s ...... carcinoma of the head and neck

@ast

Randomized phase II trial of s ...... carcinoma of the head and neck

@en

type

Item

label

Randomized phase II trial of s ...... carcinoma of the head and neck

@ast

Randomized phase II trial of s ...... carcinoma of the head and neck

@en

prefLabel

Randomized phase II trial of s ...... carcinoma of the head and neck

@ast

Randomized phase II trial of s ...... carcinoma of the head and neck

@en

P1476

Randomized phase II trial of s ...... carcinoma of the head and neck

@en

P2093

Adrienne Groman

http://www.w3.org/2001/XMLSchema#string

Anurag K Singh

http://www.w3.org/2001/XMLSchema#string

Michael B Jameson

http://www.w3.org/2001/XMLSchema#string

Michael Tills

http://www.w3.org/2001/XMLSchema#string

Shiva Dibaj

http://www.w3.org/2001/XMLSchema#string

Wainwright Jaggernauth

http://www.w3.org/2001/XMLSchema#string

Youcef Rustum

http://www.w3.org/2001/XMLSchema#string

P2860

Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition

Global cancer statistics

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Smoking and drinking in relation to oral and pharyngeal cancer

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Selective nodal irradiation for head and neck cancer using intensity-modulated radiotherapy: application of RTOG consensus guidelines in routine clinical practice.

Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

P304

166-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V6.I5.166

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Mix

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282873234

http://www.w3.org/2001/XMLSchema#string

P698

26468453

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

chemoradiotherapy

P932

4600191

http://www.w3.org/2001/XMLSchema#string